Johnson & Johnson's Revenue
- Johnson & Johnson's annual revenue was $85.16B in fiscal year 2023. The annual revenue increased $5.17B from $79.99B (in 2023) to $85.16B (in 2023), representing a 6.46% year-over-year growth.
- Johnson & Johnson's quarterly revenue was $22.47B in the quarter ending Sep 2024. The quarterly revenue increased $1.12B from $21.35B (in Q3: June 2023) to $22.47B (in Q3: June 2024), representing a 5.25% year-over-year growth.
- The highest annual revenue for Johnson & Johnson was $85.16B in fiscal year 2023.
- The lowest annual revenue was $70.07B in fiscal year 2016.
- The average revenue was $78.73B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2015 - 2024):
Learn more about Johnson & Johnson's Revenue by Segment and Revenue by Region.
Check out competitors to Johnson & Johnson in a side-by-side comparison.
Explore additional financial metrics for Johnson & Johnson.
Definition of Revenue :
| 2014 | 74331000000.00 |
|---|---|
| 2016 | 70074000000.00 |
| 2017 | 71890000000.00 |
| 2017 | 76450000000.00 |
| 2018 | 81581000000.00 |
| 2019 | 82059000000.00 |
| 2021 | 82584000000.00 |
| 2022 | 78740000000.00 |
| 2023 | 79990000000.00 |
| 2023 | 85159000000.00 |
| Mar 2015 | 17374000000.00 |
|---|---|
| Jun 2015 | 17787000000.00 |
| Sep 2015 | 17102000000.00 |
| Jan 2016 | 17811000000.00 |
| Apr 2016 | 17482000000.00 |
| Jul 2016 | 18482000000.00 |
| Oct 2016 | 17820000000.00 |
| Jan 2017 | 18106000000.00 |
| Apr 2017 | 17766000000.00 |
| Jul 2017 | 18839000000.00 |
| Oct 2017 | 19650000000.00 |
| Dec 2017 | 20195000000.00 |
| Apr 2018 | 20009000000.00 |
| Jul 2018 | 20830000000.00 |
| Sep 2018 | 20348000000.00 |
| Dec 2018 | 20394000000.00 |
| Mar 2019 | 20021000000.00 |
| Jun 2019 | 20562000000.00 |
| Sep 2019 | 20729000000.00 |
| Dec 2019 | 20747000000.00 |
| Mar 2020 | 20691000000.00 |
| Jun 2020 | 18336000000.00 |
| Sep 2020 | 21082000000.00 |
| Jan 2021 | 22475000000.00 |
| Apr 2021 | 22321000000.00 |
| Jul 2021 | 23312000000.00 |
| Oct 2021 | 23338000000.00 |
| Jan 2022 | 24804000000.00 |
| Apr 2022 | 23426000000.00 |
| Jul 2022 | 24020000000.00 |
| Oct 2022 | 19996000000.00 |
| Jan 2023 | 23706000000.00 |
| Apr 2023 | 20894000000.00 |
| Jul 2023 | 21519000000.00 |
| Oct 2023 | 21351000000.00 |
| Dec 2023 | 21395000000.00 |
| Mar 2024 | 21383000000.00 |
| Jun 2024 | 22447000000.00 |
| Sep 2024 | 22471000000.00 |
| Sep 2024 | 22471000000.00 |
2023
Johnson & Johnson's annual revenue was $85.16B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $20.89B(Q1: Apr 2023), $21.52B(Q2: Jul 2023), $21.35B(Q3: Oct 2023), $21.40B(Q4: Dec 2023) in fiscal year 2023.
2023
Johnson & Johnson's annual revenue was $79.99B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $20.89B(Q1: Apr 2023), $21.52B(Q2: Jul 2023), $21.35B(Q3: Oct 2023), $21.40B(Q4: Dec 2023) in fiscal year 2023.
2022
Johnson & Johnson's annual revenue was $78.74B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $23.43B(Q1: Apr 2022), $24.02B(Q2: Jul 2022), $20.00B(Q3: Oct 2022), $23.71B(Q4: Jan 2023) in fiscal year 2022.
2021
Johnson & Johnson's annual revenue was $82.58B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $22.32B(Q1: Apr 2021), $23.31B(Q2: Jul 2021), $23.34B(Q3: Oct 2021), $24.80B(Q4: Jan 2022) in fiscal year 2021.
2019
Johnson & Johnson's annual revenue was $82.06B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $20.02B(Q1: Mar 2019), $20.56B(Q2: Jun 2019), $20.73B(Q3: Sep 2019), $20.75B(Q4: Dec 2019) in fiscal year 2019.
2018
Johnson & Johnson's annual revenue was $81.58B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $20.01B(Q1: Apr 2018), $20.83B(Q2: Jul 2018), $20.35B(Q3: Sep 2018), $20.39B(Q4: Dec 2018) in fiscal year 2018.
2017
Johnson & Johnson's annual revenue was $76.45B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $17.77B(Q1: Apr 2017), $18.84B(Q2: Jul 2017), $19.65B(Q3: Oct 2017), $20.20B(Q4: Dec 2017) in fiscal year 2017.
2017
Johnson & Johnson's annual revenue was $71.89B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $17.77B(Q1: Apr 2017), $18.84B(Q2: Jul 2017), $19.65B(Q3: Oct 2017), $20.20B(Q4: Dec 2017) in fiscal year 2017.
2016
Johnson & Johnson's annual revenue was $70.07B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $17.48B(Q1: Apr 2016), $18.48B(Q2: Jul 2016), $17.82B(Q3: Oct 2016), $18.11B(Q4: Jan 2017) in fiscal year 2016.
| 2014 | 0 |
|---|---|
| 2016 | -5.73 |
| 2017 | +2.59 |
| 2017 | +6.34 |
| 2018 | +6.71 |
| 2019 | +0.59 |
| 2021 | +0.64 |
| 2022 | -4.65 |
| 2023 | +1.59 |
| 2023 | +6.46 |
| Q1: Mar 15 | -4.09 |
|---|---|
| Q2: Jun 15 | -8.76 |
| Q3: Sep 15 | -7.39 |
| Q4: Jan 16 | 0 |
| Q1: Apr 16 | 0.62 |
| Q2: Jul 16 | 3.91 |
| Q3: Oct 16 | 4.20 |
| Q4: Jan 17 | 1.66 |
| Q1: Apr 17 | 1.62 |
| Q2: Jul 17 | 1.93 |
| Q3: Oct 17 | 10.27 |
| Q4: Dec 17 | 13.38 |
| Q1: Apr 18 | 12.63 |
| Q2: Jul 18 | 10.57 |
| Q3: Sep 18 | 3.55 |
| Q4: Dec 18 | 12.64 |
| Q1: Mar 19 | 0.06 |
| Q2: Jun 19 | -1.29 |
| Q3: Sep 19 | 1.87 |
| Q4: Dec 19 | 1.73 |
| Q1: Mar 20 | 3.35 |
| Q2: Jun 20 | -10.83 |
| Q3: Sep 20 | 1.70 |
| Q4: Jan 21 | 0 |
| Q1: Apr 21 | 7.88 |
| Q2: Jul 21 | 27.14 |
| Q3: Oct 21 | 10.70 |
| Q4: Jan 22 | 10.36 |
| Q1: Apr 22 | 4.95 |
| Q2: Jul 22 | 3.04 |
| Q3: Oct 22 | -14.32 |
| Q4: Jan 23 | -4.43 |
| Q1: Apr 23 | -10.81 |
| Q2: Jul 23 | -10.41 |
| Q3: Oct 23 | 6.78 |
| Q4: Dec 23 | -13.74 |
| Q1: Mar 24 | 2.34 |
| Q2: Jun 24 | 4.31 |
| Q3: Sep 24 | 5.25 |
| Q3: Sep 24 | 5.25 |
2023
Johnson & Johnson’s annual revenue increased +6.46% during fiscal year 2023 compared to 2023. It represents a growth of $5.17B from $79.99B (in 2023) to $85.16B (in 2023).
2023
Johnson & Johnson’s annual revenue increased +1.59% during fiscal year 2023 compared to 2022. It represents a growth of $1.25B from $78.74B (in 2022) to $79.99B (in 2023).
2022
Johnson & Johnson’s annual revenue decreased -4.65% during fiscal year 2022 compared to 2021. It represents a decline of -$3.84B from $82.58B (in 2021) to $78.74B (in 2022).
2021
Johnson & Johnson’s annual revenue increased +0.64% during fiscal year 2021 compared to 2019. It represents a growth of $525.00M from $82.06B (in 2019) to $82.58B (in 2021).
2019
Johnson & Johnson’s annual revenue increased +0.59% during fiscal year 2019 compared to 2018. It represents a growth of $478.00M from $81.58B (in 2018) to $82.06B (in 2019).
2018
Johnson & Johnson’s annual revenue increased +6.71% during fiscal year 2018 compared to 2017. It represents a growth of $5.13B from $76.45B (in 2017) to $81.58B (in 2018).
2017
Johnson & Johnson’s annual revenue increased +6.34% during fiscal year 2017 compared to 2017. It represents a growth of $4.56B from $71.89B (in 2017) to $76.45B (in 2017).
2017
Johnson & Johnson’s annual revenue increased +2.59% during fiscal year 2017 compared to 2016. It represents a growth of $1.82B from $70.07B (in 2016) to $71.89B (in 2017).
2016
Johnson & Johnson’s annual revenue decreased -5.73% during fiscal year 2016 compared to 2014. It represents a decline of -$4.26B from $74.33B (in 2014) to $70.07B (in 2016).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2023 | $85.16B | +6.46% |
| 2023 | $79.99B | +1.59% |
| 2022 | $78.74B | -4.65% |
| 2021 | $82.58B | +0.64% |
| 2019 | $82.06B | +0.59% |
| 2018 | $81.58B | +6.71% |
| 2017 | $76.45B | +6.34% |
| 2017 | $71.89B | +2.59% |
| 2016 | $70.07B | -5.73% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q3: Sep 24 | $22.47B | 5.25% |
| Q3: Sep 24 | $22.47B | 5.25% |
| Q2: Jun 24 | $22.45B | 4.31% |
| Q1: Mar 24 | $21.38B | 2.34% |
| Q4: Dec 23 | $21.40B | -13.74% |
| Q3: Oct 23 | $21.35B | 6.78% |
| Q2: Jul 23 | $21.52B | -10.41% |
| Q1: Apr 23 | $20.89B | -10.81% |
| Q4: Jan 23 | $23.71B | -4.43% |
| Q3: Oct 22 | $20.00B | -14.32% |
| Q2: Jul 22 | $24.02B | 3.04% |
| Q1: Apr 22 | $23.43B | 4.95% |
| Q4: Jan 22 | $24.80B | 10.36% |
| Q3: Oct 21 | $23.34B | 10.70% |
| Q2: Jul 21 | $23.31B | 27.14% |
| Q1: Apr 21 | $22.32B | 7.88% |
| Q4: Jan 21 | $22.48B | 0% |
| Q3: Sep 20 | $21.08B | 1.70% |
| Q2: Jun 20 | $18.34B | -10.83% |
| Q1: Mar 20 | $20.69B | 3.35% |
| Q4: Dec 19 | $20.75B | 1.73% |
| Q3: Sep 19 | $20.73B | 1.87% |
| Q2: Jun 19 | $20.56B | -1.29% |
| Q1: Mar 19 | $20.02B | 0.06% |
| Q4: Dec 18 | $20.39B | 12.64% |
| Q3: Sep 18 | $20.35B | 3.55% |
| Q2: Jul 18 | $20.83B | 10.57% |
| Q1: Apr 18 | $20.01B | 12.63% |
| Q4: Dec 17 | $20.20B | 13.38% |
| Q3: Oct 17 | $19.65B | 10.27% |
| Q2: Jul 17 | $18.84B | 1.93% |
| Q1: Apr 17 | $17.77B | 1.62% |
| Q4: Jan 17 | $18.11B | 1.66% |
| Q3: Oct 16 | $17.82B | 4.20% |
| Q2: Jul 16 | $18.48B | 3.91% |
| Q1: Apr 16 | $17.48B | 0.62% |
| Q4: Jan 16 | $17.81B | 0% |
| Q3: Sep 15 | $17.10B | -7.39% |
| Q2: Jun 15 | $17.79B | -8.76% |
| Q1: Mar 15 | $17.37B | -4.09% |
Related
-
Agilent Technologies Revenue
-
Eli Lilly and Company Revenue
-
Stryker Corporation Revenue
-
AbbVie Revenue
-
Merck & Co. Revenue
-
Thermo Fisher Scientific Revenue
-
Abbott Laboratories Revenue
-
Danaher Corporation Revenue
-
Amgen Revenue
-
Pfizer Revenue
-
Boston Scientific Corporation Revenue
-
Bristol-Myers Squibb Company Revenue
-
Cigna Corporation Revenue
-
McKesson Corporation Revenue
-
Cardinal Health Revenue
-
Moderna Revenue
